214 related articles for article (PubMed ID: 26874904)
21. Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23.
Wei Y; Wang D; Jin F; Bian Z; Li L; Liang H; Li M; Shi L; Pan C; Zhu D; Chen X; Hu G; Liu Y; Zhang CY; Zen K
Nat Commun; 2017 Jan; 8():14041. PubMed ID: 28067230
[TBL] [Abstract][Full Text] [Related]
22. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
23. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.
Yu G; Yu W; Jin G; Xu D; Chen Y; Xia T; Yu A; Fang W; Zhang X; Li Z; Xie K
Mol Cancer; 2015 Nov; 14():193. PubMed ID: 26576639
[TBL] [Abstract][Full Text] [Related]
24. Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.
Mukherjee J; Phillips JJ; Zheng S; Wiencke J; Ronen SM; Pieper RO
PLoS One; 2013; 8(2):e57610. PubMed ID: 23451252
[TBL] [Abstract][Full Text] [Related]
25. Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and -catenin pathway after spinal cord injury.
Zhang J; Feng G; Bao G; Xu G; Sun Y; Li W; Wang L; Chen J; Jin H; Cui Z
Cell Cycle; 2015; 14(16):2609-18. PubMed ID: 26151495
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
Dando I; Cordani M; Donadelli M
IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
[TBL] [Abstract][Full Text] [Related]
27. UBE4B regulates p27 expression in A549 NSCLC cells through regulating the interaction of HuR and the p27 5' UTR.
Kim H; Jung SY; Yun HH; Yoo K; Lee JS; Lee JH
Biochem Biophys Res Commun; 2024 Feb; 695():149484. PubMed ID: 38211530
[TBL] [Abstract][Full Text] [Related]
28. Organ-Specific MicroRNAs (
Taniguchi K; Sugito N; Shinohara H; Kuranaga Y; Inomata Y; Komura K; Uchiyama K; Akao Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695138
[TBL] [Abstract][Full Text] [Related]
29. PKM2 regulates chromosome segregation and mitosis progression of tumor cells.
Jiang Y; Li X; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; Wei C; Guo F; Chen Y; Lu Z
Mol Cell; 2014 Jan; 53(1):75-87. PubMed ID: 24316223
[TBL] [Abstract][Full Text] [Related]
30. Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
Muralidharan R; Babu A; Amreddy N; Basalingappa K; Mehta M; Chen A; Zhao YD; Kompella UB; Munshi A; Ramesh R
J Nanobiotechnology; 2016 Jun; 14(1):47. PubMed ID: 27328938
[TBL] [Abstract][Full Text] [Related]
31. Delivery of Therapeutics Targeting the mRNA-Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth.
Huang YH; Peng W; Furuuchi N; Gerhart J; Rhodes K; Mukherjee N; Jimbo M; Gonye GE; Brody JR; Getts RC; Sawicki JA
Cancer Res; 2016 Mar; 76(6):1549-59. PubMed ID: 26921342
[TBL] [Abstract][Full Text] [Related]
32. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells.
de Wit RH; Mujić-Delić A; van Senten JR; Fraile-Ramos A; Siderius M; Smit MJ
Oncotarget; 2016 Oct; 7(42):67966-67985. PubMed ID: 27602585
[TBL] [Abstract][Full Text] [Related]
33. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
Guo M; Zhao X; Yuan X; Jiang J; Li P
Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells.
Guo CY; Yan C; Luo L; Goto S; Urata Y; Xu JJ; Wen XM; Kuang YK; Tou FF; Li TS
Oncol Rep; 2017 Apr; 37(4):2161-2166. PubMed ID: 28259998
[TBL] [Abstract][Full Text] [Related]
35. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization.
Lv L; Xu YP; Zhao D; Li FL; Wang W; Sasaki N; Jiang Y; Zhou X; Li TT; Guan KL; Lei QY; Xiong Y
Mol Cell; 2013 Nov; 52(3):340-52. PubMed ID: 24120661
[TBL] [Abstract][Full Text] [Related]
36. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
Zhang Z; Huang A; Zhang A; Zhou C
Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
[TBL] [Abstract][Full Text] [Related]
37. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
Li C; Zhao Z; Zhou Z; Liu R
Dig Dis Sci; 2016 Mar; 61(3):767-73. PubMed ID: 26500118
[TBL] [Abstract][Full Text] [Related]
38. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
[TBL] [Abstract][Full Text] [Related]
39. Emerging roles of PKM2 in cell metabolism and cancer progression.
Luo W; Semenza GL
Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
[TBL] [Abstract][Full Text] [Related]
40. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
